HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pityriasis rubra pilaris successfully treated with adalimumab.

AuthorsS Schreml, V Zeller, P Babilas, S Karrer, M Landthaler, R-M Szeimies
JournalClinical and experimental dermatology (Clin Exp Dermatol) Vol. 35 Issue 7 Pg. 792-3 (Oct 2010) ISSN: 1365-2230 [Electronic] England
PMID20345992 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • Tumor Necrosis Factor-alpha
  • Adalimumab
Topics
  • Adalimumab
  • Aged
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents (therapeutic use)
  • Humans
  • Male
  • Pityriasis Rubra Pilaris (drug therapy)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: